Synaptogenix Inc (SNPX)

[InTheTrenches]

Interesting NY Times review of the book "THE BREAKTHROUGH Immunotherapy and the Race to Cure Cancer."

https://www.nytimes.com/2019/01/07/books/review/breakthrough-charles-graeber.html?action=click&module=Discovery&pgtype=Homepage

This quote from the article looks like a parallel to what might happen here with Alkon, the synapse theory, PKC-e and Bryostatin:

"That moment [late 19th century] could have signaled the beginning of the field of immunotherapy and, perhaps, the beginning of a new way to fight cancer — but no one else in the medical field bought it. Instead, as Graeber points out, Coley was relegated to quackdom, and the conventional, respectable treatments for cancer remained those of surgery, chemotherapy and radiation — “cut, burn and poison” in the words of the author and the medical establishment he writes about. It is simplistic but probably accurate to say that most cancer research went in the wrong direction early and stayed there: The conventional wisdom held that it was best to attack the disease instead of looking for ways to help the body heal itself."